Summary & Overview
HCPCS J0591: Injection, Deoxycholic Acid, 1 mg
HCPCS Level II code J0591 denotes an injectable dose of deoxycholic acid, 1 mg. This code captures the drug component for procedures involving deoxycholic acid, commonly used in localized soft-tissue contouring and related indications. Nationally, accurate coding for injectable agents like deoxycholic acid matters for clinical documentation, payer coverage determinations, and consistent drug utilization reporting.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of coverage considerations and payer presence, benchmarks for utilization where available, and the clinical context for use of deoxycholic acid injections. The publication outlines how the code is used on service lines for outpatient and office-based procedures, typical sites of service, and what data elements are available or missing for deeper reimbursement analysis.
This summary provides national-level context for clinicians, billing staff, and policy analysts seeking to understand how HCPCS Level II code J0591 is classified and where it fits within procedural workflows. Data not available in the input is identified where applicable.
Billing Code Overview
HCPCS Level II code J0591 represents an injection of deoxycholic acid, 1 mg, a pharmacologic agent used for injectable procedures. The service type is an injectable medication administration for localized soft-tissue contouring or related indications where deoxycholic acid is indicated. The typical site of service is an outpatient clinic, ambulatory surgery center, or office-based procedural setting, where injectable cosmetic or therapeutic soft-tissue treatments are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to a dermatology or cosmetic surgery clinic seeking reduction of submental fullness ("double chin") due to localized subcutaneous fat. The patient has persistent submental adiposity after lifestyle measures and desires a minimally invasive alternative to liposuction. The clinician (dermatologist, plastic surgeon, or otolaryngologist) performs a focused assessment of medical history, medication use, allergy status, prior procedures, and physical examination of the submental region, documenting pinch thickness, skin laxity, and anatomy of the marginal mandibular nerve and platysma. Pre-procedure counseling and informed consent are completed, including discussion of common adverse events (swelling, bruising, numbness, pain, dysphagia) and expected number of treatment sessions.
On the day of service the procedure is performed in an outpatient clinic procedure room. Local anesthesia (topical and/or local infiltrative) is administered. Markings identify treatment grid points in the preplatysmal submental fat. The clinician injects deoxycholic acid (billed as J0591 per mg) into multiple subcutaneous locations using small-gauge needles, with dose and number of injections documented precisely. Post-procedure instructions and follow-up plan are provided. Billing includes the appropriate HCPCS code J0591 with quantity reflecting total milligrams administered and applicable modifiers to reflect circumstances (for example, patient status or unusual services). Documentation includes informed consent, injection sites and doses, anesthesia, adverse events, and follow-up arrangement.
Coding Specifications
| Modifier | Description | When to Use |
|---|